MRNA Moderna Inc
Company Analysis
Latest News
🟢 Moderna is trading 6% up today as investors refocus on positive melanoma vaccine results
Moderna is trading 5.67% up at $146.77 after renewed investor attention to positive Phase 3 results for its personalized melanoma vaccine. - Moderna and Merck...
🔴 Moderna is trading 7.35% down today
Moderna is trading 7.35% down at $134.47 after no new company-specific announcement was identified for August 24, 2026. • The decline follows an exceptionally...
🟢 Moderna is trading 12.41% up today after recovering from August 20’s 23.55% drop
Moderna is trading $149.86 (+12.41%) after recovering from the August 20 profit-taking decline. • The decline was 23.55%, following the prior session’s...
🟢 Moderna is trading 10.23% up today after a 23.55% fall on August 20 following profit-taking
Moderna is trading at $146.96, up 10.23%, rebounding after heavy profit-taking following its 176.97% surge on August 19. - Shares fell 23.55% to $133.32 on...
🟢 Moderna is trading 8.5% up today after a 23.55% fall on August 20
Moderna is trading at $144.62, up +8.47%, rebounding after falling 23.55% to $133.32 on August 20. - No clear new company-specific catalyst was identified for...
🟢 Moderna is trading 5% up in pre-market with no clear company-specific catalyst
Moderna is trading 5.15% up now at $140.19 after a sharp prior-session pullback, with no clear fresh company-specific catalyst for the rebound. - The Phase 3...
🔴 Moderna is trading 18% down today after profit-taking from August 19 surge
Moderna is trading at $143.77 (-17.55%) after apparent profit-taking following its August 19 surge. - Shares surged 176.97% on August 19 to $174.38. - The...
🔴 Moderna is trading 11.2% down in pre-market after apparent profit-taking following August 19's 176.97% surge
Moderna is trading 11.2% down at $154.91 after investors appeared to take profits following its 176.97% regular-session surge on August 19. - The rally...
🔴 Moderna is trading 5.5% down in after-hours trading after 176.97% regular-session surge
Moderna is trading 5.5% down at $164.77, apparently due to profit-taking after its exceptional regular-session rally. - It closed at $174.38 on August 19,...
🟢 Moderna is trading 11.26% up in after-hours trading after positive Phase 3 melanoma vaccine results
Moderna is trading at $194.02 (+11.26%) after the company and Merck reported positive Phase 3 results for their personalized mRNA melanoma vaccine. -...
Moderna's Stock Doubles on Cancer Vaccine Breakthrough — But Can a Company Burning Cash Grow Into a $50 Billion Valuation?
Shares of Moderna surged as much as 104.8% to $128.92 Wednesday after the company and partner Merck announced that their personalized mRNA cancer vaccine hit...
🟢 Moderna is trading 102.38% up today after Phase 3 melanoma trial success
Moderna is trading 102.38% up at $128.92 after its personalized mRNA cancer vaccine, developed with Merck, met the primary recurrence-free-survival endpoint in...
🟢 Moderna is trading 4.09% up today after FDA approval of first mRNA flu vaccine
Moderna is trading 4.09% up now at $63.05 after renewed attention to the FDA’s approval of mFlusiva, its first mRNA-based seasonal flu vaccine. - Approved for...
🟢 Moderna is trading 4.3% up in pre-market after FDA approval of mFLUSIVA
Moderna is trading at $61.70, up +4.28%, after the FDA approved mFLUSIVA, its first mRNA-based seasonal flu vaccine. - The approval covers adults aged 50 and...
Moderna's First mRNA Flu Shot Clears the FDA — But Can It Actually Crack a Market Dominated by Entrenched Giants?
Shares surged +6.2% to $57.19 after the FDA approved Moderna's seasonal mRNA flu vaccine for adults 50 and older — the first influenza shot ever built on mRNA...
🟢 Moderna is trading 6.3% up today after FDA approves mFlusiva
Moderna is trading at $57.19, up +6.26%, on August 7, 2026, after the FDA approved mFlusiva, its seasonal mRNA flu vaccine for adults aged 50 and older. - The...
🔴 Moderna is trading 4.1% down today despite FDA approval for mFLUSIVA
Moderna is trading at $53.95, with a -4.10% change (4.1% down) on August 6, 2026, despite FDA approval of its mFLUSIVA seasonal flu vaccine. - The approval...
🟢 Moderna is trading 4% up today on mRNA flu vaccine FDA focus and improved cost controls
Moderna is trading 4% up at $58.53 in pre-market as traders focus on the upcoming FDA decision for its mRNA-1010 flu vaccine and recently improved Q2 cost...
🟢 Moderna is trading 4.04% up today on mRNA-1010 flu vaccine FDA decision date
Moderna is trading at $59.30 (+4.04%) as investors focus on the upcoming FDA decision date for its mRNA-1010 flu vaccine. • The stock is also supported by...
🟢 Moderna is trading 4.1% up today ahead of Aug 5 FDA flu vaccine decision
Moderna is trading 4.1% up today at $57.41, rebounding from recent post-earnings volatility as the broader biotech sector rallies. • Investors are positioning...